October 26, 2007

Barr Pharmaceuticals’ $2.8B of Senior Unsecured Debt Rated ‘BBB-’

Standard & Poor’s Ratings Services today assigned its ‘BBB-’ corporate credit rating to generic drug maker Barr Pharmaceuticals Inc.

More: continued here

Permalink Print
Made with WordPress and an easy to use WordPress theme • Strawberry Cream, Classic skin by Antonella Pavese